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 The oral surgeons are frequently asked to manage
patients who are receiving oral anticoagulants.
 The goal of treatment is to minimize the risk of
hemorrhage while continuing to protect the
patient against thromboembolism formation.
 The ordinary treatment includes the interruption
of anticoagulant therapy for oral surgery
interventions to prevent hemorrhage.
 However, this practice may logically increase the
risk of a potentially life-threatening
thromboembolism. Thus, this issue is still
controversial.
 The aim of the study was to evaluate the
mouthwash solution (tranexamic acid) as a local
haemostatic modality after oral surgery
interventions.
 To realize the aim 100 individuals who received oral anticoagulants 
were included. 
 Oral surgery interventions were performed with a reduction in the 
level of anticoagulant therapy in the first group. 
 Oral surgery interventions were realized in the second group with no 
change in the level of anticoagulant therapy and with usage the 
tranexamic acid. 
Patients
(n=100)
First Group 
(with reduction of 
oral anticoagulans)
Second Group 
(without reduction of 
oral anticoagulans) 
number 50 50
Gendr 
(male/female)
28 / 22 23 / 27
Age range 65.1 +10 62.7 + 6.1
INR  (normal value1) 1.79 +0.2 2.8 +0.3
Table 1. Anticoagulated patients undergoing oral surgery 
treatment: gender, age, and INR value
RESULTS: The analysis showed that there was no significant difference between the 
two treatment groups in the bleeding incidence after oral surgery interventions. 
 The anticoagulant treatment does not need to be withdrawn 
before oral surgery provided that local antifibrinolytic therapy 
is instituted. 
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